Knee pain that limits walking, climbing stairs, or sleeping pushes many people toward a difficult choice between living on anti-inflammatories and scheduling a joint replacement. Between those two extremes sits a group of regenerative options, and stem cell therapy for knees is one of the most discussed among them. For patients with osteoarthritis or a stubborn joint injury who want to protect their own knee rather than replace it, the meaningful questions are how the treatment works, where the cells are actually placed, and what the current evidence supports.
Those questions matter more than they might seem, because the results of a stem cell procedure depend heavily on which structure inside the knee is targeted. Understanding that difference, along with the conditions the treatment addresses and who tends to benefit, is what separates an informed decision from a hopeful one.
What Is Stem Cell Therapy for the Knee?
Stem cell therapy is a form of regenerative medicine that uses the body’s own repair cells to support healing inside a damaged joint. The cells most often used are mesenchymal stem cells (MSCs), which are found in bone marrow and adipose tissues; each is capable of releasing signaling molecules that reduce inflammation and encourage tissue repair.
In a knee procedure, these cells are collected, concentrated, and injected into carefully selected structures in and around the joint. The approach used at Compass relies on autologous cells, meaning they come from the patient’s own body, most commonly drawn from bone marrow. Because the cells are the patient’s own, the risk of allergic reaction or immune rejection is minimal, and the procedure avoids the regulatory and safety questions associated with donor-derived or laboratory-expanded cell products.
How Does Stem Cell Therapy Work in the Knee?
Mesenchymal stem cells act as coordinators of repair rather than simple replacement parts. Once concentrated and placed into a damaged area, they release growth factors and signaling proteins that reduce local inflammation, recruit other reparative cells, and support the maintenance of surrounding tissue. In laboratory settings, MSCs can also differentiate into specialized cells such as cartilage and bone, which is part of why they have drawn so much research interest for joint disease. This cellular signaling activity is well established.
What is still being studied is how much of that biological activity produces durable, structural change in an actual arthritic knee. This is where the difference in technique becomes central, because the same cells can be delivered to very different targets, and the target appears to influence the result far more than most patients expect.
Placement Changes the Outcome
Most regenerative clinics inject stem cells intra-articularly, meaning into the fluid inside the joint space. It is the easier technique, but a growing body of evidence suggests it is not where the cells do the most good over the long term. Research comparing the two approaches has found that delivering stem cells into the subchondral bone, the dense layer directly beneath the cartilage, produces longer-lasting relief and a substantially higher chance of avoiding surgery than joint-space injection alone. One long-term study of patients facing knee replacement found that subchondral treatment helped a much larger share of knees avoid surgery than intra-articular injection over the follow-up period.
The reasoning behind this is mechanical and biological at once. Osteoarthritis is not simply worn-out cartilage; it is a disease of the whole joint, including the bone beneath the cartilage, where painful bone marrow lesions and inflammation often appear early. Targeting that bone treats a structure that standard joint injections never reach, which is why technique and imaging skill matter as much as the cells themselves.
What Knee Conditions Can It Treat?
Stem cell therapy for knees can be considered for degenerative and overuse conditions as well as acute injuries that might otherwise indicate surgical repair. The conditions where it is most often used include:
Knee osteoarthritis
Cartilage thinning and early degenerative change
ligament or tendon injuries such as ACL, PCL, and MCL tears
Ongoing knee pain that has not responded to physical therapy, activity changes, or medication
What Does the Evidence Show?
The evidence for stem cell therapy in the knee has grown substantially, and it is genuinely encouraging. Multiple systematic reviews of randomized trials have found that MSC injections are superior to placebo for reducing pain and improving function at the twelve-month mark, and long-term data on subchondral bone-marrow treatment show sustained improvement along with measurable changes on MRI, including reduction of painful bone marrow lesions and preservation of joint space. These are not small findings; they point to treatment that can influence the joint itself, not just the sensation of pain.
What the research makes equally clear is that results depend on how the treatment is done. Cell source, dose, preparation, and above all the target of the injection vary widely across studies, and the strongest, most durable outcomes consistently come from precise, image-guided placement into the structures that actually drive the disease. This is why outcomes differ so much between providers, and why technique and diagnostic accuracy matter as much as the cells themselves. The treatment is a serious, evidence-backed option for the right patient, matched to the right target, by a provider with the skill to deliver it.
Who May Be a Candidate?
Deciding whether stem cell therapy fits a particular knee depends on the stage of degeneration, the structures involved, the patient’s overall health, and what has already been tried. A thorough evaluation typically includes imaging and a functional assessment to identify which structures are contributing to pain, because the source of the problem determines whether and where cells should be placed.
Candidacy is also where appropriate caution belongs. A good evaluation is as much about identifying who should not have the procedure, such as a patient whose joint is too far degenerated to benefit, as it is about confirming who should. That screening step is what allows the treatment itself to be offered with confidence when it is offered at all.
Making a Decision About Stem Cell Therapy for Your Knee
For the right patient, stem cell therapy offers a way to treat the underlying joint rather than replace it, with the strongest long-term evidence pointing toward precise, image-guided placement into the subchondral bone rather than a simple injection into the joint space. It is not a fit for every knee, and advanced arthritis may still be better served by surgery, but for mild to moderate disease it is a serious option worth understanding.
The single most important factor a patient can weigh is not whether stem cells work in the abstract, but whether the provider has the diagnostic skill and image-guided technique to place them where they matter. Treatment at Compass is built around that principle, using cellular therapy matched to the specific structures driving each patient’s pain. Anyone considering stem cell therapy for knees is best served by starting with an evaluation that identifies exactly what is generating the pain and whether targeted regenerative treatment can address it.
